The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 509
Comparison Between Permeability Coefficients in Rat and Human Jejunum
Fagerholm, U., Johansson, M., & Lennernäs, H. (1996) · Pharmaceutical Research · doi:10.1023/a:1016065715308 · Cited by 438
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 426
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement
Varma, M. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00158-0 · Cited by 418
Self-citationNanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Feng, S.-S., Mu, L., Win, K., & Huang, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455909 · Cited by 311
P-Glycoprotein Increases from Proximal to Distal Regions of Human Small Intestine
Mouly, S., & Paine, M. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1026183200740 · Cited by 276
Yamazaki, M., Neway, W. E., Ohe, T., Chen, I.-W., Rowe, J. F., Hochman, J. H., Chiba, M., & Lin, J. H. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38809-3 · Cited by 238
Yu, L., Bridgers, A., Polli, J., Vickers, A., Long, S., Roy, A., Winnike, R., & Coffin, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018939006780 · Cited by 225
Pharmaceutical aspects of paclitaxel
Panchagnula, R. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00188-4 · Cited by 220
Self-citationPAMPA—a drug absorption in vitro model
Bermejo, M., Avdeef, A., Ruiz, A., Nalda, R., Ruell, J. A., Tsinman, O., González, I., Fernández, C., Sánchez, G., Garrigues, T. M., et al. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.10.009 · Cited by 206
van Asperen, J., van Tellingen, O., Sparreboom, A., Schinkel, A., Borst, P., Nooijen, W., & Beijnen, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.530 · Cited by 202
Theoretical and Experimental Studies of Transport of Micelle-Solubilized Solutes
Amidon, G. E., Higuchi, W. I., & Ho, N. F. H. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710120 · Cited by 192
Yang, S., Gursoy, R. N., Lambert, G., & Benita, S. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016238.44452.f1 · Cited by 169
Varma, M. V. S., Sateesh, K., & Panchagnula, R. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0499196 · Cited by 161
Self-citationTroutman, M. D., & Thakker, D. R. (2003) · Pharmaceutical Research · doi:10.1023/a:1025001131513 · Cited by 159
Malingré, M. M., Beijnen, J. H., & Schellens, J. H. M. (2001) · Investigational New Drugs · doi:10.1023/a:1010635000879 · Cited by 158
Kinetic Profiling of P-glycoprotein-Mediated Drug Efflux in Rat and Human Intestinal Epithelia
Stephens, R. H., O’Neill, C. A., Warhurst, A., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38782-8 · Cited by 149
Nerurkar, M. M., Ho, N. F. H., Burton, P. S., Vidmar, T. J., & Borchardt, R. T. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960483y · Cited by 139
van Asperen, J., van Tellingen, O., van der Valk, M. A., Rozenhart, M., & Beijnen, J. H. (1998) · PubMed · Cited by 138
Collett, A., Higgs, N. B., Sims, E. J., Rowland, M., & Warhurst, G. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37939-x · Cited by 136
Oral absorption of the HIV protease inhibitors: a current update
Williams, G. C., & Sinko, P. J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00027-7 · Cited by 136
Woo, J. S., Lee, C. H., Shim, C. K., & Hwang, S. (2003) · Pharmaceutical Research · doi:10.1023/a:1022286422439 · Cited by 133
Dhanikula, A. B., & Panchagnula, R. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00087-3 · Cited by 126
Self-citationThe effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers*
Chang, T. T., Benet, L. Z., & Hébert, M. F. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80007-5 · Cited by 122
Studies on the cyclosporin A loaded stearic acid nanoparticles
Zhang, Q., Yie, G., Li, Y., Yang, Q., & NAGAI, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00361-6 · Cited by 114
Varma, M., Khandavilli, S., Ashokraj, Y., Jain, A., Dhanikula, A., Sood, A., Thomas, N., Pillai, O., Sharma, P., Gandhi, R., et al. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335423 · Cited by 107
Self-citationSOKOL, R., Johnson, K. E., Karrer, F. M., Narkewicz, M. R., Smith, D. J., & Kam, I. (1991) · The Lancet · doi:10.1016/0140-6736(91)90349-t · Cited by 82
Varma, M. V. S., & Panchagnula, R. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20309 · Cited by 78
Self-citationAno, R., Kimura, Y., Shima, M., Matsuno, R., Ueno, T., & Akamatsu, M. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.10.002 · Cited by 73
Stephens, R. H., O’Neill, C. A., Bennett, J., Humphrey, M., Henry, B., Rowland, M., & Warhurst, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704668 · Cited by 51
Kimura, Y., Aoki, J., Kohno, M., O'OKA, H., Tsuruo, T., & Nakanishi, O. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0419-x · Cited by 51
Siegmund, W., Ludwig, K., Engel, G., Zschiesche, M., Franke, G., Hoffmann, A., Terhaag, B., & Weitschies, W. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10327 · Cited by 36
Boudreaux, J. P., Hayes, D. H., Mizrahi, S. S., Maggiore, P., Blazek, J., & Dick, D. (1993) · PubMed · Cited by 36
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Vitamin E TPGS as a molecular biomaterial for drug delivery
Zhang, Z., Tan, S., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.046 · Cited by 586
The applications of Vitamin E TPGS in drug delivery
Guo, Y., Luo, J., Tan, S., Otieno, B. O., & Zhang, Z. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.006 · Cited by 523
Oral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Metadata
- Authors
- Varma, M. V. S., & Panchagnula, R.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 25
- Issue
- 4-5
- Pages
- 445-453
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2091400260
- Cited by
- 361
- References
- 37
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.